|
6UNP
Crystal structure of the kinase domain of BMPR2-D485G
Deposited 2019-10-13
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
188–529(342 aa)
Fragment:kinase domain
|
Mutation:D485G
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ADP ADENOSINE-5'-DIPHOSPHATE × 2
MG MAGNESIUM ION × 7
SO4 SULFATE ION × 3
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;277 K;0.1 M Na Cacodylate, pH 6.0, 0.3 M Ammonium sulfate, 22% w/v PEG 8000
|
Resolution 2.30 Å
R-free 0.211
|
|
6UNP
Crystal structure of the kinase domain of BMPR2-D485G
Deposited 2019-10-13
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
188–529(342 aa)
Fragment:kinase domain
|
Mutation:D485G
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ADP ADENOSINE-5'-DIPHOSPHATE × 1
MG MAGNESIUM ION × 11
SO4 SULFATE ION × 2
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;277 K;0.1 M Na Cacodylate, pH 6.0, 0.3 M Ammonium sulfate, 22% w/v PEG 8000
|
Resolution 2.30 Å
R-free 0.211
|
|
7PPA
High resolution structure of bone morphogenetic protein receptor type II (BMPRII) extracellular domain in complex with BMP10
Deposited 2021-09-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
27–150(124 aa)
Chain D
27–150(124 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.8;294.15 K;14% PEG 3350
0.19 M Ammonium citrate dibasic
0.02 M Sodium citrate tribasic dihydrate
|
Resolution 1.48 Å
R-free 0.207
|
|
7PPB
2.4 angstrom crystal structure of bone morphogenetic protein receptor type II (BMPRII) extracellular domain in complex with BMP10
Deposited 2021-09-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
27–150(124 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;294.15 K;14% PEG 3350
0.14 M KCl
|
Resolution 2.40 Å
R-free 0.235
|
|
7PPC
Ternary signalling complex of BMP10 bound to ALK1 and BMPRII
Deposited 2021-09-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain I
27–150(124 aa)
Chain J
27–150(124 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;294.15 K;20% PEG 3350
0.2 M Calcium acetate hydrate
|
Resolution 3.60 Å
R-free 0.282
|
|
7PPC
Ternary signalling complex of BMP10 bound to ALK1 and BMPRII
Deposited 2021-09-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain K
27–150(124 aa)
Chain L
27–150(124 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;294.15 K;20% PEG 3350
0.2 M Calcium acetate hydrate
|
Resolution 3.60 Å
R-free 0.282
|
|
7U5O
CRYSTAL STRUCTURE OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE 2 LIGAND BINDING DOMAIN IN COMPLEX WITH ACTIVIN-B
Deposited 2022-03-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
27–137(111 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.4;294 K;175 mM Ammonium Sulfate
100 mM Bis Tris
14% PEG 3000
|
Resolution 3.45 Å
R-free 0.284
|
|
7U5O
CRYSTAL STRUCTURE OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE 2 LIGAND BINDING DOMAIN IN COMPLEX WITH ACTIVIN-B
Deposited 2022-03-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
27–137(111 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.4;294 K;175 mM Ammonium Sulfate
100 mM Bis Tris
14% PEG 3000
|
Resolution 3.45 Å
R-free 0.284
|
|
7U5O
CRYSTAL STRUCTURE OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE 2 LIGAND BINDING DOMAIN IN COMPLEX WITH ACTIVIN-B
Deposited 2022-03-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain G
27–137(111 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.4;294 K;175 mM Ammonium Sulfate
100 mM Bis Tris
14% PEG 3000
|
Resolution 3.45 Å
R-free 0.284
|